Results 11 to 20 of about 397 (134)
Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
Indian Journal of Dermatology, 2019 Context: Androgenic alopecia (AGA) is a hereditary androgen-dependent disorder, characterized by gradual conversion of terminal hair into miniaturized hair and defined by various patterns. Common age group affected is between 30 and 50 years.
Rita V Vora +3 more
doaj +1 more source
Molecules, 2022 There is a growing demand for hair loss treatments with minimal side effects and recurrence potential. Connarus semidecandrus Jack has been used as a folk medicine for fever in tropical regions, but its anti-alopecia effects remain unclear. In this study,
Won Young Jang +12 more
doaj +1 more source
Androgenic alopecia; the risk–benefit ratio of Finasteride
Journal of Mind and Medical Sciences, 2018 Finasteride is currently approved and largely used as a therapeutic option for androgenetic alopecia. Apparently a safe drug and effective at the onset, several concerns appeared over time regarding the frequency and magnitude of finasteride adverse ...
David L. Rowland +6 more
doaj +1 more source
Pakistan Armed Forces Medical Journal, 2022 Objective: To compare the effect of topical liquid Nitrogen and normal saline on pain during intradermal Platelet-rich Plasma therapy in androgenic alopecia. Study Design: Prospective Comparative study.
Moizza Tahir +5 more
doaj +1 more source
Efficacy of platelet-rich plasma in treatment of androgenic alopecia
Asian Journal of Transfusion Science, 2015 Background: Platelet-rich plasma (PRP) has shown remarkable beneficial effects without any major adverse reactions in the treatment of androgenic alopecia.
Parul Singhal +3 more
doaj +1 more source
The Importance of Vitamin-D in Androgenic Alopecia and Telogen Effluvium [PDF]
Ķazaķstannyṇ Klinikalyķ Medicinasy, 2018 Aim: Androgenic alopecia (AA) is defined as progressive miniaturization of scarless hair follicle prevailing among both male and female. Telogen effluvium (TE) is the most common hair loss form accompanying systemic diseases.
Gülbahar Saraç, Tuba Tülay Koca
doaj +1 more source
Future Journal of Pharmaceutical Sciences, 2022 Background Melatonin (MEL) is a powerful antioxidant molecule with anti-androgenic property. A microemulsion (ME) system loaded with MEL was designed for treatment of androgenic alopecia. Pseudo-ternary phase diagram was constructed, and ME formulae were
Asmaa A. Elshall +4 more
doaj +1 more source
Trichology features of alopecia in reproductive age women with polycystic ovary syndrome
Acta Biomedica Scientifica, 2017 Background. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5-10 % of reproductive-aged women. The dermatologic manifestations of PCOS play a significant role in diagnosis. The purpose of the present study was to
L. V. Belenkaya +4 more
doaj +1 more source
Metabolic syndrome in androgenic alopecia
Indian Journal of Dermatology, Venereology, and Leprology, 2016 Androgenic alopecia has been associated with an increased risk of coronary heart disease in various studies. The relationship between androgenic alopecia and metabolic syndrome, a known risk factor for atherosclerotic cardiovascular disease, is still poorly understood.To study the association between metabolic syndrome and early-onset androgenic ...
Hima, Gopinath, Gatha M, Upadya
openaire +2 more sources
Androgenic alopecia: an entity to consider in adolescence [PDF]
BMJ Case Reports, 2017 A 15-year-old healthy adolescent girl went to her physician consultation because she was preoccupied with progressive thinning of her hair since 11 years old. In the last year, she noticed an aggravation, with an excessive hair loss. She does not have hirsutism, acne, asthenia, menstrual irregularities or weight variations.
Rodrigues, M +3 more
openaire +3 more sources